Loading data
DOGZNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 15.88 m USD | 20.71 m USD | 14.85 m USD | 17.58 m USD | 27.1 m USD |
| Cost of revenue | 13.34 m USD | 15.68 m USD | 11.73 m USD | 13.92 m USD | 16.96 m USD |
| Gross profit | 2.55 m USD | 5.03 m USD | 3.12 m USD | 3.66 m USD | 10.14 m USD |
| Research and development expense | 956.86 k USD | 1.12 m USD | 610.44 k USD | 931.08 k USD | 917.23 k USD |
| Operating profit | -28.81 m USD | -6.79 m USD | -7.53 m USD | -9.56 m USD | 74.06 k USD |
| Interest expense | — | — | — | 330.82 k USD | 370.11 k USD |
| Profit before tax | -28.82 m USD | -6.18 m USD | -6.55 m USD | -8.69 m USD | 238.26 k USD |
| Income tax expense | -1.19 m USD | -1.08 m USD | -491.6 k USD | -1.23 m USD | -2.78 m USD |
| Net income (reported basis) | -27.63 m USD | -5.1 m USD | -6.06 m USD | -7.2 m USD | 3.24 m USD |
| Basic earnings per share | -1.55 USD/share | -0.38 USD/share | -0.55 USD/share | -0.68 USD/share | 0.31 USD/share |
| Diluted earnings per share | -1.55 USD/share | -0.38 USD/share | -0.55 USD/share | -0.68 USD/share | 0.31 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.